Stock Events
Stock Events
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Agios Pharmaceuticals (8AP.MU) Q2 2026 Earnings
8AP.MU
29
Apr
Confirmed
Q1 2026
Q2 2026
-1.65
-1.58
-1.51
-1.45
Details
Expected EPS
-1.54421278316
Actual EPS
-1.4471132
Surprise EPS
0.1
Surprise Percent
+6.29%
Description
Agios Pharmaceuticals (8AP.MU) has reported earnings of -1.4471132 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist